About Phoremost
Phoremost is a company based in Cambridge (United Kingdom) founded in 2015.. Phoremost has raised $76.8 million across 6 funding rounds from investors including XtalPi, Cambridge Enterprise and Cambridge Angels. The company has 32 employees as of March 31, 2021. Phoremost offers products and services including SITESEEKER Technology. Phoremost operates in a competitive market with competitors including Rheonix, 64x Bio, reMYND, Molcure and Adaptyv Biosystems, among others.
- Headquarter Cambridge, United Kingdom
- Employees 32 as on 31 Mar, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Phoremost Limited
- Date of Incorporation 01 Apr, 2014
- Jurisdiction PAMPISFORD, UNITED KINGDOM
-
Annual Revenue
$1.04 M (USD)13as on Mar 31, 2022
-
Net Profit
$-10.31 M (USD)-61as on Mar 31, 2022
-
EBITDA
$-12.52 M (USD)-68as on Mar 31, 2022
-
Total Equity Funding
$76.8 M (USD)
in 6 rounds
-
Latest Funding Round
$12 M (USD), Series B
Sep 10, 2024
-
Investors
XtalPi
& 13 more
-
Employee Count
32
as on Mar 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Phoremost
Phoremost offers a comprehensive portfolio of products and services, including SITESEEKER Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for identifying novel targets in oncology and protein degradation fields
Unlock access to complete
Unlock access to complete
Funding Insights of Phoremost
Phoremost has successfully raised a total of $76.8M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $12 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $12.0M
- First Round First Round
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series B - Phoremost | Valuation | Parkwalk | |
| Mar, 2021 | Amount | Series B - Phoremost | Valuation | BGF | |
| May, 2018 | Amount | Series A - Phoremost | Valuation | Amadeus Capital , Cambridge Enterprise |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Phoremost
Phoremost has secured backing from 14 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include XtalPi, Cambridge Enterprise and Cambridge Angels. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Founded Year | Domain | Location | |
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Phoremost
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Phoremost
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Phoremost Comparisons
Competitors of Phoremost
Phoremost operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rheonix, 64x Bio, reMYND, Molcure and Adaptyv Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a drug pipeline programs for neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
AI-based platform for drug discovery and antibody detection is provided.
|
|
| domain | founded_year | HQ Location |
Protein design, synthesis, testing, and validation services are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Phoremost
Frequently Asked Questions about Phoremost
When was Phoremost founded?
Phoremost was founded in 2015.
Where is Phoremost located?
Phoremost is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Phoremost a funded company?
Phoremost is a funded company, having raised a total of $76.8M across 6 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Mar 01, 2015.
How many employees does Phoremost have?
As of Mar 31, 2021, the latest employee count at Phoremost is 32.
What is the annual revenue of Phoremost?
Annual revenue of Phoremost is $1.04M as on Mar 31, 2022.
What does Phoremost do?
Phoremost develops a phenotypic screening platform to identify specific targetspathways. The companys proprietary Protein Interference technology (PROTEINi) is a live-cell assay system that probes for the druggable sites across the whole human genome. It has also developed Site-Seekerplatform which is a phenotypic screening platform that identifies the new targets for drug development. Its lead therapeutic program has identified drug candidates to synthetic lethal target for KRAS which is a viral oncogene homolog.
Who are the top competitors of Phoremost?
What products or services does Phoremost offer?
Phoremost offers SITESEEKER Technology.
Who are Phoremost's investors?
Phoremost has 14 investors. Key investors include XtalPi, Cambridge Enterprise, Cambridge Angels, Parkwalk, and BGF.